CAD (protein)

CAD
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases CAD, CDG1Z, carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
External IDs MGI: 1916969 HomoloGene: 1412 GeneCards: CAD
Orthologs
Species Human Mouse
Entrez

790

69719

Ensembl

ENSG00000084774

ENSMUSG00000013629

UniProt

P27708

B2RQC6

RefSeq (mRNA)

NM_001306079
NM_004341

NM_001289522
NM_001289523
NM_023525

RefSeq (protein)

NP_001293008.1
NP_004332.2

NP_001276451.1
NP_076014.1

Location (UCSC) Chr 2: 27.22 – 27.24 Mb Chr 5: 31.05 – 31.08 Mb
PubMed search [1] [2]
Wikidata
View/Edit HumanView/Edit Mouse
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
Identifiers
Symbol CAD
Entrez 790
HUGO 1424
OMIM 114010
RefSeq NM_004341
UniProt P27708
Other data
EC number 2.1.3.2
Locus Chr. 2 p21

CAD protein (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase) is a trifunctional multi-domain enzyme involved in the first three steps of pyrimidine biosynthesis. De-novo synthesis starts with cytosolic carbamoylphosphate synthetase II which uses glutamine, carbon dioxide and ATP. This enzyme is inhibited by uridine triphosphate (feedback inhibition).

In 2015, the first observed pathological mutations of CAD were found in a four-year-old boy.[3]

References

  1. "Human PubMed Reference:".
  2. "Mouse PubMed Reference:".
  3. Ng, B. G.; Wolfe, L. A.; Ichikawa, M.; Markello, T.; He, M.; Tifft, C. J.; Gahl, W. A.; Freeze, H. H. (12 February 2015). "Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors". Human Molecular Genetics. 24 (11): 3050–3057. doi:10.1093/hmg/ddv057.

External links

This article is issued from Wikipedia - version of the 11/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.